OMNEON™ the type 2 diabetes clinical research study program
Which disease is being investigated?
Type 2 diabetes: After you eat, your food is broken down into sugars that are used as energy for the cells in your body. The main sugar is called glucose. Insulin is a hormone that helps glucose enter the cells. Sometimes, the body is unable to make enough insulin to meet its needs or is unable to properly use the insulin it makes to help the cells take up glucose from the blood to generate energy. When this happens, type 2 diabetes can develop. Type 2 diabetes is the most common form of diabetes affecting adults and is characterized by high blood glucose levels. High blood glucose levels can result in complications affecting the eyes, kidneys and nerves of patients if diabetes remains uncontrolled for a long period of time. Many factors can increase the chances of developing type 2 diabetes, including:
- Excessive weight (obesity)
- Inactive lifestyle
- Poor food choices
- Family history
The OMNEON™ Program
OMNEON™ is a clinical research study program for patients with type 2 diabetes. The purpose of the different trials in the program is to determine the safety and effectiveness of a new investigational medicine in pill/tablet form.
Who may participate in the trial?
You may qualify if you are
- 18 years of age and older and
- have been diagnosed with type 2 diabetes.
Your next steps
- See if you qualify by completing an online questionnaire
- Have your contact details and answers to the questionnaire submitted to a participating study site of your choice
- Be contacted by study staff for further information